Karis Bio
PrivateLast Round
Series B
Dec 1, 2024
Total Funding Raised
$17.18M
Company Overview
Karis Bio is a biotechnology company that develops regenerative cell therapies using induced pluripotent stem cell (iPSC) technology to treat cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Karis Bio Comparables
Compare Karis Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cuorips Inc. | 77% | |
| IPS HEART | 75% | |
| Bayer AG | 69% |
Karis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2024 | ||||
| Series A | May 1, 2021 | ||||
| Angel | Dec 1, 2020 |
Karis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Premier Partners | Series B, Series A |
| Devsisters Ventures | Series B, Series A |
| Korea Development Bank | Series B, Series A |
| Korea Venture Investment Corporation | Series B |
| AJU IB Investment | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2024
$8M round with participation from Devsisters Ventures and Premier Partners.
- Dec 1, 2020
Completed an Angel funding round.
Karis Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Karis Bio's valuation, stock price, and market status.
Is Karis Bio a public or private company?
Karis Bio is a private company.
What is the current stock price of Karis Bio?
Karis Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Karis Bio worth (valuation)?
Valuation information for Karis Bio is not publicly available.
Can I buy Karis Bio stock?
Karis Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Karis Bio's last funding round?
Karis Bio's most recent funding round was Series B on December 1, 2024.
Who are the main investors in Karis Bio?
Key investors in Karis Bio include Premier Partners, Devsisters Ventures, Korea Development Bank, Korea Venture Investment Corporation, AJU IB Investment.
Will Karis Bio IPO soon?
No public IPO plans have been announced for Karis Bio.
How can I track Karis Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Karis Bio's secondary market activity and sign up for updates.